11.10
Dbv Technologies Adr (DBVT) 最新ニュース
European ADRs Dip As Pharma And Tech Stocks See Mixed Results - Finimize
DBV Technologies Sets Critical Shareholder Meeting: Key Documents Now Available - Stock Titan
European ADRs Show Modest Gains With Standout Performers - Finimize
StockNews.com Upgrades DBV Technologies (NASDAQ:DBVT) to “Hold” - Defense World
FY2025 EPS Forecast for DBV Technologies Boosted by Analyst - Defense World
European ADRs Dip With Mixed Performances Across Key Sectors - Finimize
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A.DBVT - Barchart.com
HC Wainwright Issues Positive Forecast for DBV Technologies (NASDAQ:DBVT) Stock Price - Defense World
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference - The Manila Times
DBV Technologies CEO Set for Key Presentation: How to Watch Live Fireside Chat at JMP Conference - Stock Titan
DBV Technologies stock target raised to $16 by H.C. Wainwright - Investing.com Nigeria
JMP Securities Boosts DBV Technologies (NASDAQ:DBVT) Price Target to $15.00 - Defense World
DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - Defense World
DBV Technologies Reports First Quarter 2025 Financial Results - EIN News
DBV Technologies Secures Massive $306.9M Financing Despite Q1 Losses: Cash Runway Extended - Stock Titan
European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize
European ADRs Show Gains Despite Mixed Performances In Key Sectors - Finimize
European Stocks Shine In The US With Strong Gains - Finimize
StockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World
Vaxcyte (NASDAQ:PCVX) versus DBV Technologies (NASDAQ:DBVT) Critical Survey - The AM Reporter
DBV Technologies (NASDAQ:DBVT) & Vaxcyte (NASDAQ:PCVX) Critical Contrast - Defense World
DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document - Informazione.it
DBV Technologies S.A. SEC 10-K Report - TradingView
DBV Technologies Completes Dual-Market Financial Filings for 2024 - Stock Titan
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading - TradingView
DBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.com - Defense World
European ADRs Show Mixed Fortunes In US Market - Finimize
European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading - TradingView
DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World
European ADRs See Mixed Results With Biopharma Leading Gains - Finimize
Why DBV Technologies (DBVT) Stock Is Skyrocketing - Benzinga
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView
US Stocks Likely To Open Lower, Analysts Warn 'Prolonged Uncertainty Could Hurt Both US And Global Risk Assets' - Benzinga
DBV Technologies announces up to $307M financing to advance Viaskin Peanut program - MSN
DBV Technologies Announces Financing of up to $306.9 - GlobeNewswire
Major Breakthrough: $306.9M Funding Powers Revolutionary Peanut Allergy Patch to FDA Finish Line - Stock Titan
大文字化:
|
ボリューム (24 時間):